(Q70113968)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3998937%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

title

Ticarcillin/clavulanic acid pharmacokinetics in children and young adults with cystic fibrosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3998937%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

1 reference

1 reference

3

G L Kearns

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3998937%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

author name string

R F Jacobs

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3998937%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

J M Trang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3998937%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

R H Warren

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3998937%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

A L Brown

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3998937%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

F L Underwood

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3998937%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

R B Kluza

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3998937%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

language of work or name

English

0 references

publication date

1 June 1985

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3998937%20AND%20SRC:MED&resulttype=core&format=json

The Journal of Pediatrics

8 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3998937%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

volume

106

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3998937%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3998937%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

page(s)

1001-1007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3998937%20AND%20SRC:MED&resulttype=core&format=json

Comparative In Vitro Activity and Clinical Pharmacology of Ticarcillin and Carbenicillin

8 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980258-4

Treatment of pulmonary infections in patients with cystic fibrosis: A comparative study of ticarcillin and gentamicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980258-4

Selective media for the quantitation of bacteria in cystic fibrosis sputum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980258-4

In vitro synergistic properties of clavulanic acid, with ampicillin, amoxycillin and ticarcillin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980258-4

Combined Activity of Clavulanic Acid and Ticarcillin Against Ticarcillin-Resistant, Gram-Negative Bacilli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980258-4

Dosing implications of altered gentamicin disposition in patients with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980258-4

Pharmacokinetics of tobramycin in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980258-4

Pharmacokinetics of Methicillin in Patients with Cystic Fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980258-4

Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980258-4

Assay of amoxicillin and clavulanic acid, the components of Augmentin, in biological fluids with high-performance liquid chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980258-4

ESTRIP, a BASIC computer program for obtaining initial polyexponential parameter estimates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980258-4

A microcomputer program in Basic for iterative, non-linear data-fitting to pharmacokinetic functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980258-4

Statistical estimations in pharmacokinetics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980258-4

Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980258-4

Assessment of Pharmacokinetic Constants from Postinfusion Blood Curves Obtained after I.V. Infusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980258-4

Statistical moments in pharmacokinetics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980258-4

Noncompartmental determination of the steady-state volume of distribution for any mode of administration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980258-4

Ticarcillin compared with carbenicillin in the treatment of exacerbations of bronchopulmonary infection in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980258-4

Ticarcillin: pharmacokinetics in man according to different administration schedules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980258-4

Pharmacokinetics of ticarcillin in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980258-4

Azlocillin pharmacokinetics in patients with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980258-4

Cloxacillin absorption and disposition in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980258-4

Pharmacokinetics and bioavailability of intramuscular preparations of ticarcillin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980258-4

Pharmacokinetics and drug distribution during postnatal development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980258-4

Clinical pharmacokinetics in infants and children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980258-4

10.1016/S0022-3476(85)80258-4

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3998937%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

1 reference